- Wood DM, Alsahaf H, Streete P, Dargan PI, and Jones AL (2005): Fatality after deliberate ingestion of the pesticide rotenone: a case report. Crit Care; 9(3):280–284.
- Tanner CM, Kamel F, Ross GW, Hoppin JA, Goldman SM, Korell M; Marras C, Bhudhikanok GS, Kasten M, Chade AR, Comyns K, Richards MB, Meng C, Priestley B, Fernandez HH, Cambi F, Umbach DB, Blair A, Sandler DP and Langston JW. (2011): Rotenone, Paraquat and Parkinson’s Disease. Environmental Health Perspectives; 119 (6): 866–872.
- Markham A, Cameron I and Bains R. (2012): Brain-derived neurotrophic factor-mediated effects on mitochondrial respiratory coupling and neuroprotection share the same molecular signalling pathways. Eur J Neurosci; 35:366–374.
- .Ren Y and Feng J. (2007): Rotenone selectively kills serotonergic neurons through a microtubule-dependent mechanism. J Neurochem; 103:303-311.
- A, Monser L and Adhoum N. (2010): Removal of rotenone insecticide by adsorption onto chemically modified activated carbons. J Hazard Mater; 181:692-699.
- . Gomez C, Bandez MJ and Navarro A. (2007): Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome. Front Biosci; 12:1079–1093.
- . Wirdefeldt K, Adami HO, Cole P, Trichopoulos D and Mandel J. (2011): Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol; 26:1–58.
- Jankovic J. (2008): Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psych; 79:368–376.
- . Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad, and Larsen M. (2008): Epidemiology of Parkinson's disease. J Neurol; 255:18–32.
- Joers V and Emborg M. (2009): Preclinical assessment of stem cell therapies for neurological diseases. ILAR J; 51:24–41.
- Karin W, Hans-Olov A, Philip C, Dimitrios T and Jack M. (2011): Epidemiology and etiology of Parkinson’s disease: a review of the evidence. Eur J Epidemiol; 26:1-58.
- Sadeghian M, Marinova-Mutafchieva L, Broom L, Davis J, Virley D and Medhurst A. (2012): Full and partial peroxisome proliferation-activated receptor-gamma agonists, but not delta agonist, rescue of dopaminergic neurons in the 6-OHDA parkinsonian model is associated with inhibition of microglial activation and MMP expression. J Neuroimmunol; 246:69–77.
- Horsfall L, Petersen I, Walters K and Schrag A. (2013): Time trends in incidence of Parkinson’s disease diagnosis in UK primary care. J Neurol; 260:1351-1357.
- Lesage S and Brice A. (2009): Parkinson's disease: From monogenic forms to genetic susceptibility factors. Hum Mol Genet; 18:48–59.
- Zaitone SA, Abo- Elmatty DM and Elshazly SM. (2012):Piracetam and vinpocetine ameliorate rotenone induced Parkinsonism in rats. Indian J Pharmacol; 44:774-779.
- Budde MD, Kim JH, Liang HF, Schmidt RE, Russell JH and Cross AH. (2007): Toward accurate diagnosis of white matter pathology using diffusion tensor imaging. Magn Reson Med; 57:688–695.
- Lennington JB, Pope S, Goodheart AE, Drozdowicz L, Daniels SB and Salamone JD. (2011): Midbrain dopamine neurons associated with reward processing innervate the neurogenic subventricular zone. J Neurosci; 31:13078-13087.
- . Watabe-Uchida M, Zhu L, Ogawa SK, amanrao A and Uchida N. (2012): Whole-Brain Mapping of Direct Inputs to Midbrain Dopamine Neurons. Neuron; 74:858-873.
- Wrangel CV, Schwabe K, John N, Krauss JK and Alam M. (2015): The rotenone-induced rat model of Parkinson's disease: Behavioral and electrophysiological findings. Behav Br Res; 279:52-61.
- Wood DM, Alsahaf H, Streete P, Dargan PI, and Jones AL (2005): Fatality after deliberate ingestion of the pesticide rotenone: a case report. Crit Care; 9(3):280–284.
- Schuler F and Casida JE (2001): Functional coupling of PSST and ND1 subunits in NADH: ubiquinone oxidoreductase established by photo affinity labeling. Biochem Biophys Acta; 1506:79–87.
- Pan T, Rawal P, Wu Y, Xie W, Jankovic J and Le W. (2009): Rapamycin protects against rotenone-induced apoptosis through autophagy induction. Neurosci; 164: 541-551.
- Alam A and Schmidt WJ (2002): Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats. Behav Brain Res; 136:317–324.
- Kim H, Park H, Park H and Chung J. (2009): Tranexamic acid protects against rotenone induced apoptosis in human neuroblastoma SH-SY5Y cells. Toxicol; 262:171–174.
- Barreto GE (2012): Mitochondrial functions in astrocytes: neuroprotective implications from oxidative damage by rotenone. Neurosci Res; 74:80–90.
|